Status:
TERMINATED
Team Approach to Polypharmacy Evaluation and Reduction in a Long-Term Care Setting
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Labarge Optimal Aging
Canadian Frailty Network
Conditions:
Long-term Care
Polypharmacy
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Medication side effects and interactions between medications are very common in older adults and are related to negative health outcomes. In this study, the investigators will test a new process aimed...
Detailed Description
There are substantial associations between polypharmacy and reduced function from older adults and this is likely to be important in frail older adults both in long term care and in the community. The...
Eligibility Criteria
Inclusion
- residing in 2 long-term care facilities in Brampton, ON
- on 5 or more long-term medications
- 70 years of age or older
- adequate English language
Exclusion
- terminal illness or other circumstance precluding 6 month study period
- recent (within 12 months) comprehensive medication review
Key Trial Info
Start Date :
October 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04055896
Start Date
October 15 2019
End Date
March 30 2021
Last Update
June 7 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Holland Christian Homes - Faith Manor
Brampton, Ontario, Canada, L6Y 5P2
2
Holland Christian Homes - Grace Manor
Brampton, Ontario, Canada, L6Y 5P2